PAZOLONG 200MG TABLET contains Pazopanib which belongs to the group of medicines called Protein kinase inhibitors. It is used in the treatment of kidney cancer (that has advanced or spread to other organs) and soft tissue sarcoma.
Soft tissue sarcoma is a type of cancer that affects the supportive tissues of the body. It can occur in the muscles, blood vessels, fat tissues or other tissues that support, surround and protect the organs.
Your doctor may ask you to undergo certain diagnostic tests to check the functioning of your liver, kidney and heart and may monitor your blood pressure prior to and while you take PAZOLONG 200MG TABLET.
Before taking [GBNKEWYORD], consult with your doctor if you have any heart, kidney or liver diseases, had lung problems, thyroid problems, bleeding or blood clotting issues, stomach or bowel problems (perforation or fistula), aneurysm (enlargement and weakening of a blood vessel wall) or have high blood pressure.
PAZOLONG 200MG TABLET is not recommended in pregnant and breastfeeding women. PAZOLONG 200MG TABLET is not recommended in children and adolescents below 18 years of age. Consult with your doctor before taking PAZOLONG 200MG TABLET.
The most common side effects of PAZOLONG 200MG TABLET are indigestion, bloating, flatulence, nosebleed, dry mouth, mouth ulcers or dizziness. Consult with your doctor if the symptoms do not improve or get worse.
Treats:
PAZOLONG 200MG TABLET works by stopping the activity of various growth factor receptors associated with blood vessel formation and tumour cell proliferation. It inhibits the activity of few other factors that are responsible for the multiplication of cancer cells and hence prevents the growth and spread of cancer cells.
Take PAZOLONG 200MG TABLET as advised by your doctor. Swallow PAZOLONG 200MG TABLET along with a glass of water. Do not crush or chew the medicine. Your doctor will decide the proper dose and duration of PAZOLONG 200MG TABLET for you depending upon the age, body weight and disease condition.
Stop taking PAZOLONG 200MG TABLET and consult with your doctor if you experience any of the following symptoms:
Diarrhoea:
Drink lots of fluids, such as water or fruit juice to keep yourself hydrated. Do not consume any medicine on your own without consulting your doctor. Ask for your doctor’s advice if diarrhoea doesn’t improve.
Nausea:
Take PAZOLONG 200MG TABLET at least two hours before the meal of one hour after a meal. Stick to simple meals while taking PAZOLONG 200MG TABLET. Avoid eating rich or spicy food. Do not take any medication on your own. Ask for your doctor’s advice if nausea doesn’t improve.
Headache:
Try to take rest and don’t involve yourself in exertive activities. Rest in a quiet and dark room. Apply a pain-relieving balm on your forehead. Ask for your doctor’s advice if headache doesn’t improve.
Vomiting:
Drink clear or ice-cold drinks. Eat light, bland foods and avoid fried, oily or sweet foods. Avoid carbonated drinks. Ask for your doctor’s advice if vomiting doesn’t improve.
Dizziness:
Lie or sit down immediately when you feel dizzy. If you're feeling severe episode of spinning(vertigo), lie in a dark and quite place with eyes closed. Try to avoid vehicle driving. Discuss with your doctor if the symptom worsens.
Stomach pain:
Try to rest and relax. Try to have smaller and frequent meals. Keep a heat pad on your stomach. Take your physicians advice.
Flatulence:
Eat smaller and frequent meals. Eat and drink slow and exercise regularly. If it does not improve, contact your doctor.
Loss of appetite:
Eat when you are hungry. Eat a nutritious snack rich in calories and protein, such as dried fruit and nuts. If the symptom does not show improvement, consult your doctor.
PAZOLONG 200MG TABLET is not recommended for use in pregnant women. Consult with your doctor before taking PAZOLONG 200MG TABLET if you are pregnant or are planning to get pregnant.
PAZOLONG 200MG TABLET is not recommended in breastfeeding women. Check with your doctor before taking [GBNKEWYORD] if you are breastfeeding.
Do not drive or using machines if you feel dizzy, tired or weak or if your energy levels are low taking PAZOLONG 200MG TABLET.
PAZOLONG 200MG TABLET should be used with caution patients having kidney diseases. Check with your doctor before taking PAZOLONG 200MG TABLET.
PAZOLONG 200MG TABLET should be used with caution patients having liver diseases. Check with your doctor before taking PAZOLONG 200MG TABLET.
Do not take PAZOLONG 200MG TABLET if you are allergic to Pazopanib or any other ingredients of this medicine.
PAZOLONG 200MG TABLET should be used with caution in patients having lung diseases such as a history of lung collapse. Contact your doctor before taking PAZOLONG 200MG TABLET.
PAZOLONG 200MG TABLET should be used with caution patients having heart diseases. Check with your doctor before taking PAZOLONG 200MG TABLET.
Before taking PAZOLONG 200MG TABLET, inform your doctor if you have:
Use in Pediatrics:
PAZOLONG 200MG TABLET is not recommended in children and adolescents below 18 years of age. Consult with your child’s doctor before giving PAZOLONG 200MG TABLET to your child.
Use in Geriatrics:
PAZOLONG 200MG TABLET can be used in elderly patients. However, ask for your doctor’s advice before taking PAZOLONG 200MG TABLET.
A. Drug-drug interactions:
Before taking PAZOLONG 200MG TABLET, inform your doctor if you are taking any of the following medicines:
Overdosage:
If you or anyone else accidentally take too much of PAZOLONG 200MG TABLET, consult your doctor immediately or visit the nearby hospital. Symptoms of overdosage of PAZOLONG 200MG TABLET may include very high blood pressure.
Drug | : | Pazopanib |
Pharmacological Category | : | Protein kinase inhibitor |
Therapeutic Indication | : | Kidney cancer, Soft tissue Sarcoma |
Dosage Forms | : | Tablet |
Can [GBNKYWORD] be given to children?
No, PAZOLONG 200MG TABLET is not recommended in children and adolescents below 18 years of age especially in children under the age of 2 years. Inform and consult with your doctor before taking PAZOLONG 200MG TABLET.
Are there any foods or drinks that I should avoid while taking PAZOLONG 200MG TABLET?
Yes, consumption of grapefruit juice is not recommended while taking PAZOLONG 200MG TABLET as it may increase the chances of getting side effects. Some common side effects of taking PAZOLONG 200MG TABLET are headache, nausea, vomiting and stomach pain. Contact your doctor if the symptoms get worse or do not improve.
Can I drive while taking PAZOLONG 200MG TABLET?
Taking PAZOLONG 200MG TABLET can have side effects that may affect your ability to drive or use machines. Do not drive or use machines if you feel dizzy, tired or weak or if your energy levels are low. Inform your doctor before taking PAZOLONG 200MG TABLET.
Should PAZOLONG 200MG TABLET be taken with or without meals?
Don’t take PAZOLONG 200MG TABLET with food. You should take it either at least two hours after a meal or one hour before a meal. For example, you could take PAZOLONG 200MG TABLET two hours after breakfast or one hour before lunch. Take PAZOLONG 200MG TABLET at about the same time each day which will make it easy for you to remember taking your medicine. Ask for your doctor’s advice if you have any further questions regarding PAZOLONG 200MG TABLET.
Do I need to undergo any tests before or while taking PAZOLONG 200MG TABLET?
Your doctor may ask you to undergo certain diagnostic tests to check the functioning of your liver, kidney and heart, levels of blood cells and may monitor your blood pressure prior to and while you take PAZOLONG 200MG TABLET.
Is PAZOLONG 200MG TABLET a form of chemotherapy?
No, PAZOLONG 200MG TABLET is not a chemotherapy treatment but it is an oral drug used to treat cancer. It is one of many targeted drug therapy. Targeted drug therapies targets proteins that control how cancer cells grow, divide and spread. PAZOLONG 200MG TABLET helps slow down the growth of blood vessels that feed tumour growth.
1. Sean C Sweetman. Antineoplastics. Martindale-The Complete Drug Reference. Thirty Sixth Edition. 2009. Page - 761.
2. Hamberg P, Verweij J, Sleijfer S. (Pre-) clinical pharmacology and activity of pazopanib, a novel multikinase angiogenesis inhibitor. NIH National Library of Medicine; National centre for biotechnology information. Pubmed Central. June 2010 [Accessed on 30th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227994/
3. Méndez-Vidal, M. J., Molina, Á., Anido, U., Chirivella, I., Etxaniz, O., Fernández-Parra, E., Guix, M., Hernández, C., Lambea, J., Montesa, Á., Pinto, Á., Ros, S., & Gallardo, E. (2018). Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma. NIH National Library of Medicine; National centre for biotechnology information. Pubmed Central. November 2018. [Accessed on 30th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258404/
4. Kasper B, Hohenberger P. Pazopanib: a promising new agent in the treatment of soft tissue sarcomas. NIH National Library of Medicine; National centre for biotechnology information. Pubmed.gov. December 2011. [Accessed on 30th May 2022]. https://pubmed.ncbi.nlm.nih.gov/22112314/
5. Novartis Pharmaceuticals UK Limited. Electronic Medicines Compendium (EMC). [Revised in December 2021] [Accessed on 30th May 2022] https://www.medicines.org.uk/emc/files/pil.572.pdf
6. Torrent Pharmaceuticals Ltd. Pazobrite (Pazopanib). [Accessed on 30th May 2022] https://www.torrentian.com/pisheet/Upload/PI_Sheet/3063.pdf
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.